GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea
2023-10-26
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
Daiichi Sankyo Advances Care Standards with Groundbreaking Cancer Treatment
2023-10-20
Takeda Initiates Voluntary Withdrawal of EXKIVITY Following Trial Outcomes
2023-10-04
Kyowa Kirin’s Strategic Partner Sandoz KK Receives Nod for Rituximab Biosimilar
2023-10-03
FDA Approves First Treatment for Fibrodysplasia Ossificans Progressiva
2023-08-21
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
Bavarian Nordic Closes on Valneva in Chikungunya Vaccine Race
2023-08-14
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
FDA Approves GSK’s PD-1 Medicine for Early-Detected Endometrial Cancer
2023-08-06
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
The First Non-prescription Oral Contraceptive approved by FDA
2023-07-18
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
FDA Approves Pfizer’s Human Growth Hormone Drug
2023-07-03
The Gates Foundation and Wellcome Join Forces to Fund Late-Stage Tuberculosis Vaccine
2023-06-29
1 2 3 4 50
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top